Radiomics signature: a potential biomarker for the prediction of disease-free survival in early-stage (I or II) non—small cell lung cancer

Y Huang, Z Liu, L He, X Chen, D Pan, Z Ma, C Liang… - Radiology, 2016 - pubs.rsna.org
Purpose To develop a radiomics signature to estimate disease-free survival (DFS) in
patients with early-stage (stage I–II) non–small cell lung cancer (NSCLC) and assess its …
被引用次数：686 相关文章
[PDF] radiomicsworld.com

[PDF][PDF] radiomics signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non–Small Cell Lung Cancer1

Y Huang, Z Liu, L He, MPX Chen, D Pan, Z Ma… - personalized … - radiomicsworld.com
Purpose: To develop a radiomics signature to estimate disease-free survival (DFS) in
patients with early-stage (stage I–II) non–small cell lung cancer (NSCLC) and assess its …

Radiomics Signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non—Small Cell Lung Cancer

Y Huang, Z Liu, L He, X Chen, D Pan, Z Ma, C Liang… - Radiology, 2016 - pubs.rsna.org
Purpose To develop a radiomics signature to estimate disease-free survival (DFS) in
patients with early-stage (stage I–II) non–small cell lung cancer (NSCLC) and assess its …

[引用][C] Radiomics Signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non—Small Cell Lung Cancer

Y Huang, Z Liu, L He, X Chen, D Pan, Z Ma, C Liang… - Radiology, 2016 - cir.nii.ac.jp
Radiomics Signature: A Potential Biomarker for the Prediction of Disease-Free Survival in
Early-Stage (I or II) Non—Small Cell Lung Cancer | CiNii Research CiNii 国立情報学研究所 学術 …
[PDF] researchgate.net

[PDF][PDF] radiomics signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non–Small Cell Lung Cancer1

Y Huang, Z Liu, L He, MPX Chen, D Pan, Z Ma… - personalized … - researchgate.net
Purpose: To develop a radiomics signature to estimate disease-free survival (DFS) in
patients with early-stage (stage I–II) non–small cell lung cancer (NSCLC) and assess its …

Radiomics Signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non-Small Cell Lung Cancer

Y Huang, Z Liu, L He, X Chen, D Pan, Z Ma… - …, 2016 - pubmed.ncbi.nlm.nih.gov
Purpose To develop a radiomics signature to estimate disease-free survival (DFS) in
patients with early-stage (stage I-II) non-small cell lung cancer (NSCLC) and assess its …